Aga Khan Health Services
11
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.2%
2 terminated/withdrawn out of 11 trials
75.0%
-11.5% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Newborn Care Kit to Save Lives in GB, Pakistan
Role: collaborator
ECD Newborn Parenting Education Program
Role: collaborator
Effectiveness of SNF and SBCC to Prevent Stunting Among Children in Afghanistan: a Quasi-experimental Study
Role: collaborator
Linking Facility-based Mortality Audits With Community Engagement in Gilgit-Baltistan, Pakistan
Role: collaborator
Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home Births
Role: collaborator
Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home Births
Role: collaborator
Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities
Role: collaborator
Community-based Perinatal and Newborn Care in Gilgit District, Northern Areas, Pakistan: an AKU-AKHSP Collaboration
Role: collaborator
Misoprostol in the Treatment of Postpartum Hemorrhage
Role: collaborator
Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan
Role: collaborator
Kabul Vitamin D Supplementation Trial
Role: collaborator
All 11 trials loaded